ASS1 and breast carcinoma: Furthermore, ASS1 is associated with chemoresistance, invasion, recurrence, and poor clinical outcomes, including breast cancer, HCC, renal cell carcinoma, and prostate cancer [10, 13, 14], in which ASS1 expression is lost [8, 10, 11].